SCHEMBL1241187

SCHEMBL1241187

CC(C)(C)OC(=O)N[C@@](C)(Cc1ccc(I)cc1)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
ALOX12 P18054 1/20 0.40
MAPK1 P28482 1/20 0.40
THPO P40225 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
AKT1 P31749 2/20 0.39
PTPRB P23467 1/20 0.39
ITGB3 P05106 1/20 0.39
ITGA2B P08514 1/20 0.39
PPARA Q07869 5/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6107393 0.87 KDM4E (0.43) KDM4EALDH1A1LMNACYP1A2POLB
SCHEMBL2573120 0.87 BLM (0.50) KDM4EALDH1A1LMNACYP1A2POLB
SCHEMBL2982712 0.87 BLM (0.50) KDM4EALDH1A1LMNACYP1A2POLB
SCHEMBL6107394 0.87 KDM4E (0.43) KDM4EALDH1A1LMNACYP1A2POLB
SCHEMBL1552723 0.87 CA12 (0.50) ALDH1A1CYP3A4AKT1ITGB3ITGA2B
SCHEMBL1350805 0.87 CA12 (0.50) ALDH1A1CYP3A4AKT1ITGB3ITGA2B
SCHEMBL1350802 0.87 CA12 (0.50) ALDH1A1CYP3A4AKT1ITGB3ITGA2B
SCHEMBL13269823 0.86 CTSS (0.50) KDM4EALDH1A1LMNACYP1A2POLB
SCHEMBL10290105 0.86 CTSS (0.50) KDM4EALDH1A1LMNACYP1A2POLB
SCHEMBL20338607 0.86 CTSS (0.50) KDM4EALDH1A1LMNACYP1A2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7884204-B2 such as (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-(4-hydroxy-1-methyl-2-oxo-1,2-dihydro-3-quinolinyl)phenyl]propionic acid, used for the teratment of inflammatory diseases, arthritis, inflammatory bowel diseases, lupus, multiple syndrome, asthma, psoriasis, allergies, diabetes and cardiovascular diseases AJINOMOTO CO., INC. (JP) 2011-02-08 US disclosed